Relapse Multiple Myeloma Clinical Trials in Chicago, Illinois
2 recruitingChicago, Illinois
Showing 1–2 of 2 trials
Recruiting
Phase 2
MMRC Horizon One: RRMM (MMRC-099)
Refractory Multiple MyelomaRelapse Multiple Myeloma
Multiple Myeloma Research Consortium300 enrolled13 locationsNCT06171685
Recruiting
Phase 2
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
Multiple MyelomaRelapse Multiple Myeloma
University of Chicago83 enrolled1 locationNCT05789303